BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31364749)

  • 21. Regulator of G-protein signalling 3 and its regulator microRNA-133a mediate cell proliferation in gastric cancer.
    Li W; Si X; Yang J; Zhang J; Yu K; Cao Y
    Arab J Gastroenterol; 2020 Dec; 21(4):237-245. PubMed ID: 32928707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer.
    Kabil N; Bayraktar R; Kahraman N; Mokhlis HA; Calin GA; Lopez-Berestein G; Ozpolat B
    Breast Cancer Res Treat; 2018 Oct; 171(3):593-605. PubMed ID: 29971628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-613 inhibits cell migration and invasion by downregulating Daam1 in triple-negative breast cancer.
    Xiong H; Yan T; Zhang W; Shi F; Jiang X; Wang X; Li S; Chen Y; Chen C; Zhu Y
    Cell Signal; 2018 Apr; 44():33-42. PubMed ID: 29339084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
    Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
    Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constructing a novel prognostic model for triple-negative breast cancer based on genes associated with vasculogenic mimicry.
    Ren Y; Feng L; Tan Z; Zhou F; Liu S
    Aging (Albany NY); 2024 May; 16(9):8086-8109. PubMed ID: 38728245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-211, a direct negative regulator of CDC25B expression, inhibits triple-negative breast cancer cells' growth and migration.
    Song GQ; Zhao Y
    Tumour Biol; 2015 Jul; 36(7):5001-9. PubMed ID: 25680404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of cancerous progression and epithelial-mesenchymal transition by miR-34c-3p via modulation of MAP3K2 signaling in triple-negative breast cancer cells.
    Wu J; Li WZ; Huang ML; Wei HL; Wang T; Fan J; Li NL; Ling R
    Biochem Biophys Res Commun; 2017 Jan; 483(1):10-16. PubMed ID: 28069384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of WT1 isoforms in vasculogenic mimicry and metastatic potential of human triple negative breast cancer cells.
    Bissanum R; Lirdprapamongkol K; Svasti J; Navakanitworakul R; Kanokwiroon K
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):256-262. PubMed ID: 29024629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-940 Inhibited Cell Growth and Migration in Triple-Negative Breast Cancer.
    Hou L; Chen M; Yang H; Xing T; Li J; Li G; Zhang L; Deng S; Hu J; Zhao X; Jiang J
    Med Sci Monit; 2016 Oct; 22():3666-3672. PubMed ID: 27731867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-498 promotes proliferation and migration by targeting the tumor suppressor PTEN in breast cancer cells.
    Chai C; Wu H; Wang B; Eisenstat DD; Leng RP
    Carcinogenesis; 2018 Sep; 39(9):1185-1196. PubMed ID: 29985991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-125b-5p inhibits breast cancer cell proliferation, migration and invasion by targeting KIAA1522.
    Li Y; Wang Y; Fan H; Zhang Z; Li N
    Biochem Biophys Res Commun; 2018 Sep; 504(1):277-282. PubMed ID: 30177391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockdown of long non-coding RNA HOST2 inhibits the proliferation of triple negative breast cancer via regulation of the let-7b/CDK6 axis.
    Zhang Y; Zhang H; Kang H; Huo W; Zhou Y; Zhang Y
    Int J Mol Med; 2019 Feb; 43(2):1049-1057. PubMed ID: 30483747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer.
    Zuo Y; Li Y; Zhou Z; Ma M; Fu K
    Biomed Pharmacother; 2017 Nov; 95():922-928. PubMed ID: 28915533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-384 inhibits the progression of breast cancer by targeting ACVR1.
    Wang Y; Zhang Z; Wang J
    Oncol Rep; 2018 Jun; 39(6):2563-2574. PubMed ID: 29693185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knockdown of long non-coding RNA TP73-AS1 suppresses triple negative breast cancer cell vasculogenic mimicry by targeting miR-490-3p/TWIST1 axis.
    Tao W; Sun W; Zhu H; Zhang J
    Biochem Biophys Res Commun; 2018 Oct; 504(4):629-634. PubMed ID: 30193732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional Characterization of lncRNA152 as an Angiogenesis-Inhibiting Tumor Suppressor in Triple-Negative Breast Cancers.
    Kim DS; Camacho CV; Setlem R; Kim K; Malladi S; Hou TY; Nandu T; Gadad SS; Kraus WL
    Mol Cancer Res; 2022 Nov; 20(11):1623-1635. PubMed ID: 35997635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer‑associated fibroblast‑derived LRRC15 promotes the migration and invasion of triple‑negative breast cancer cells via Wnt/β‑catenin signalling pathway regulation.
    Yang Y; Wu H; Fan S; Bi Y; Hao M; Shang J
    Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34726255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-136 suppresses tumor invasion and metastasis by targeting RASAL2 in triple-negative breast cancer.
    Yan M; Li X; Tong D; Han C; Zhao R; He Y; Jin X
    Oncol Rep; 2016 Jul; 36(1):65-71. PubMed ID: 27108696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of ubiquitin ligase Cullin3 on the proliferation, migration and invasion of triple-negative breast cancer cells and exploration of its mechanism].
    He ZX; Li J; Wang QF; Cheng Q; Ni SJ
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1868-1878. PubMed ID: 38782756
    [No Abstract]   [Full Text] [Related]  

  • 40. MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2.
    Lv ZD; Yang DX; Liu XP; Jin LY; Wang XG; Yang ZC; Liu D; Zhao JJ; Kong B; Li FN; Wang HB
    Cell Physiol Biochem; 2017; 44(5):1785-1795. PubMed ID: 29216628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.